Harbin Medical University Cancer Hospital — Harbin

Public research footprint of Harbin Medical University Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

573

Registered studies

327

Active

189

Recruiting now

142

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Non-Small Cell Lung Cancer (NSCLC) · Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer · Carcinoma, Non-Small-Cell Lung

Recently updated registry entries

NCT05920356 — A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum… (Recruiting)
NCT07472517 — DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare… (Recruiting)
NCT06324357 — Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Harbin Medical University Cancer Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.